NEULASTA 6 mg, solution for injection syringe
Active ingredients: Pegfilgrastim
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringesous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NEULASTA 6 mg, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) sécurisée en verre de 0,6 mlavec aiguille(s) acier
- Marketing authorisation holder
- AMGEN EUROPE
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Apr 2010
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68735818CIP73953516CIP133400939535166Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PEGFILGRASTIMsolution | 6 mg · 0,6 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.